Reports

Ideas That Generate Results

 

Figure 2-1: Global - Pharmaceutical Market (in Billion US$), 2002-2007

Figure 2-2: Global - Growth of Pharmaceutical Market (%), 2002-2007

Figure 2-3: Global - Pharmaceutical Market* by Region (%), 2007

Figure 2-4: Global - Top Five Pharmaceutical Companies by Sales & Net Income (in Billion US$), 2007

Figure 3-1: Russia - Population (in Million), 2002-2007

Figure 3-2: Russia - Life Expectancy of Male & Female (in Years), 2002-2008E

Figure 3-3: Russia - Population Breakup by Age (%), 2002-2008E

Figure 3-4: Russia - Number of Doctors (per ‘000 Population), 2002-2007E

Figure 3-5: Russia - Number of Hospital Beds (per ‘000 Population), 2002-2007E

Figure 3-6: Russia - Share of Healthcare Expenditure in GDP (%), 2002-2007E

Figure 3-7: Russia - Per Capita Healthcare Expenditure (in US$), 2002-2007E

Figure 4-1: Russia - Pharmaceutical Market (in Million US$), 2006 & 2007

Figure 4-2: Russia - Share of Key Segments in Pharmaceutical Market (%), 2006 & 2007

Figure 4-3: Global - Top Pharmaceutical Retail Markets (in Billion US$), 2007

Figure 4-4: Global - Growth of Top Pharmaceutical Retail Markets (%), 2007

Figure 4-5: Global - Per Capita Drug Consumption in Top Pharmaceutical Markets (in US$), 2006

Figure 4-6: Russia - Share of Personal & State Financing in Pharmaceutical Market (%), 2004-2006

Figure 4-7: Global - Share of Personal & State Financing in Top Pharmaceutical Markets (%), 2006

Figure 4-8: Russia - Commercial Drugs Market (in Million US$), 2006 & 2007

Figure 4-9: Russia - Trends in Commercial Drugs Market (%), 2007

Figure 4-10: Russia - Share of Imported & Domestic Drugs in Commercial Drugs Market by Sales Value (%), 2006 & 2007

Figure 4-11: Russia - Share of Imported & Domestic Drugs in Commercial Drugs Market by Sales Volume (%), 2006 & 2007

Figure 4-12: Russia - Share of RX & OTC Drugs in Commercial Drugs Market by Sales Value (%), 2006 & 2007

Figure 4-13: Russia - Share of RX & OTC Drugs in Commercial Drugs Market by Sales Volume (%), 2006 & 2007

Figure 4-14: Russia - Growth* of Major ATC Groups in Commercial Drugs Market (%), 2007

Figure 4-15: Russia - Price Index for Drugs in Commercial Drugs Market (%), 2005-2007

Figure 4-16: Russia - Price Index for Imported & Domestic Drugs in Commercial Drugs Market (%), 2005-2007

Figure 4-17: Russia - Consumer Price Index (%), 2007

Figure 4-18: Russia - State Segment of Pharmaceutical Market (in Million US$), 2006 & 2007

Figure 4-19: Russia - Consumption under DLO Programme (in Billion US$), 2006* & 2007

Figure 4-20: Russia - Share of Imported & Domestic Drugs in the DLO List of Full & Trade Name (%), 2007

Figure 4-21: Russia - Share of Imported & Domestic Drugs under DLO Programme by Sales Value (%), 2006 & 2007

Figure 4-22: Russia - Share of RX & OTC Drugs under DLO Programme by Sales Value (%), 2006 & 2007

Figure 4-23: Russia - Share of RX & OTC Drugs under DLO Programme by Sales Volume (%), 2006 & 2007

Figure 4-24: Russia - Share of ATC Groups under DLO Programme by Sales Value (%), 2006 & 2007

Figure 4-25: Russia - Share of Imported & Domestic Drugs under Hospital Segment by Sales Value (%), 2006 & 2007*

Figure 4-26: Russia - Share of Imported & Domestic Drugs under Hospital Segment by Sales Volume (%), 2006 & 2007

Figure 4-27: Russia - Drugs Demand by Price under Hospital Segment (%), 2007

Figure 4-28: Russia - Parapharmaceutical Market (in Million US$), 2006 & 2007

Figure 4-29: Russia - Nutritional Supplements Market (in Million US$), 2005 & 2006

Figure 4-30: Russia - Nutritional Supplements Market (in Million Units), 2005 & 2006

Figure 4-31: Russia - Share of Imported & Domestic Nutritional Supplements Sales (%), 2006

Figure 4-32: Russia - Breakup* of Imported Nutritional Supplements by Country (%), 2006

Figure 4-33: Russia - Imported & Domestic Nutritional Supplements Demand by Price (%), 2006

Figure 4-34: Russia - Sales Structure of New Drugs by Value & Volume (%), 2007

Figure 5-1: Russia - Population aged 65 Years & Above (in Million), 2001-2007

Figure 5-2: Russia - Commercial Drugs Demand by Price (%), 2006 & 2007

Figure 5-3: Russia - Structure of Pharmaceutical Market Growth (%), 2007

Figure 5-4: Russia - Pharmaceutical Market Growth* by Segment (%), 2007

Figure 5-5: Russia - Personal Disposable Income (in Billion US$), 2002-2007E

Figure 5-6: Russia - Share of Deaths from Cardiovascular Diseases in Total Deaths (%), 2005 & 2030F

Figure 5-7: Russia - Number of HIV Patients (in Million), 2003 & 2020F

Figure 5-8: Russia - Anti-HIV Drugs Import (in Million US$), 2004 & 2005

Figure 5-9: Russia - Forecast for Number of Diagnosed Diabetes Patients* (in '000), 2003 & 2025F

Figure 5-10: Russia - Insulin Market (in Million US$), 2006E-2008F

Figure 5-11: Russia - Share of Deaths from Cancer in Total Deaths (%), 2005 & 2030F

Figure 5-12: Russia - Generic Drugs Market (in Billion Euro), 2006 & 2010F

Figure 5-13: Russia - Number of Approved Clinical Trials (2001-2006)

Figure 5-14: Russia - Number of Patients Participating in Clinical Trials (2002 & 2006)

Figure 5-15: Russia - Clinical Trials by Therapeutic Areas (%), 2007

Figure 5-16: Russia - Clinical Trials by Sponsor Country (%), 2007

Figure 5-17: Russia - Forecast for Population (in Million), 2008-2012

Figure 6-1: Russia - Forecast for Pharmaceutical Market (in Million US$), 2008-2012

Figure 6-2: Russia - Forecast for Pharmaceutical Market by Segments (%), 2012

Figure 6-3: Russia - Forecast for Population aged 65 Years & Above (in Million) 2008-2012

Figure 6-4: Russia - Forecast for Commercial Drugs Segment (in Million US$), 2008-2012

Figure 6-5: Russia - Forecast for State Segment (in Million US$), 2008-2012

Figure 6-6: Russia - Forecast for DLO Market (in Billion US$), 2008-2012

Figure 6-7: Russia - Forecast for Personal Disposable Income (in Billion US$), 2008-2012

Figure 6-8: Russia - Forecast for Parapharmaceutical Market (in Million US$), 2008-2012

 

 

Table 2-1: Global - Pharmaceutical Market by Region* (in Billion US$), 2007
Table 2-2: Global - Leading Therapy Classes by Sales* (in Billion US$), 2007
Table 2-3: Global - Leading Drugs by Sales* (in Billion US$), 2007

Table 4-1: Russia - Leading Pharmaceutical Companies by Sales (in Million US$), 2006 & 2007

Table 4-2: Russia - Sales Structure of ATC Groups in Commercial Drugs Market, 2007

Table 4-3: Russia - Leading Pharmaceutical Companies in Commercial Drugs Market by Sales (in Million US$), 2006 & 2007

Table 4-4: Russia - Leading Drugs in Commercial Drugs Market by Sales (in Million US$), 2006 & 2007

Table 4-5: Russia - Sales Structure of ATC Groups under DLO Programme, 2007

Table 4-6: Russia - Leading Pharmaceutical Companies under DLO Programme (in Million US$), 2006 & 2007

Table 4-7: Russia - Leading Drugs under DLO Programme by Sales (in Million US$), 2006 & 2007

Table 4-8: Russia - Leading Pharmaceutical Companies under Hospital Segment (%), 2007

Table 4-9: Russia - Leading Drugs under Hospital Segment by Sales (in Million US$), 2007

Table 4-10: Russia - Leading Nutritional Supplements by Sales (in Million US$), 2005 & 2006

Table 4-11: Russia - Top 20 New Trade Names on Commercial Market (in ‘000 US$), 2007

Table 7-1: Sanofi-Aventis - Key Financials (in Million Euro), 2005-2007

Table 7-2: Novartis International AG - Key Financials (in Million US$), 2005-2007

Table 7-3: Roche Group - Key Financials (in Million CHF), 2005-2007

Table 7-4: Pfizer Inc - Key Financials (in Million US$), 2005-2007

Table 7-5: AstraZeneca Plc - Key Financials (in Million US$), 2005-2007